Your browser doesn't support javascript.
One year in review 2022: systemic lupus erythematosus.
Zucchi, Dina; Elefante, Elena; Schilirò, Davide; Signorini, Viola; Trentin, Francesca; Bortoluzzi, Alessandra; Tani, Chiara.
  • Zucchi D; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy. dinazucchi@hotmail.it.
  • Elefante E; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  • Schilirò D; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  • Signorini V; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  • Trentin F; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  • Bortoluzzi A; Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S. Anna, Ferrara, Italy.
  • Tani C; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
Clin Exp Rheumatol ; 40(1): 4-14, 2022 01.
Article in English | MEDLINE | ID: covidwho-1856815
ABSTRACT
Systemic lupus erythematosus (SLE) is a chronic multisystem auto-immune disease with extremely varied clinical manifestations and a complex pathogenesis. New insights in SLE about pathogenetic pathways, biomarkers, and data on clinical manifestations are progressively emerging, and new drugs and new therapeutic strategies have been proposed to improve the control of disease activity. Thus, this review is aimed to summarise the most relevant data about SLE emerged during 2021, following the previous annual review of this series.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Lupus Erythematosus, Systemic Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal: Clin Exp Rheumatol Year: 2022 Document Type: Article Affiliation country: CLINEXPRHEUMATOL

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Lupus Erythematosus, Systemic Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal: Clin Exp Rheumatol Year: 2022 Document Type: Article Affiliation country: CLINEXPRHEUMATOL